Shares of Exicure, Inc. (NASDAQ:XCUR – Get Free Report) fell 8.7% during trading on Wednesday . The stock traded as low as $0.58 and last traded at $0.58. 30,265 shares changed hands during mid-day trading, a decline of 93% from the average session volume of 412,076 shares. The stock had previously closed at $0.64.
Exicure Price Performance
The company’s fifty day moving average price is $0.62 and its 200 day moving average price is $0.61. The company has a market cap of $5.02 million, a PE ratio of 0.35 and a beta of 1.31.
Insider Activity
In other news, major shareholder Co. Ltd. Dgp sold 3,400,000 shares of the stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $1.32, for a total value of $4,488,000.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 8.40% of the stock is currently owned by corporate insiders.
Institutional Trading of Exicure
Exicure Company Profile
Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.
See Also
- Five stocks we like better than Exicure
- Golden Cross Stocks: Pattern, Examples and Charts
- United Airlines Soars on Earnings Beat
- Breakout Stocks: What They Are and How to Identify Them
- J.B. Hunt Hits the Skids: Lower Prices to Come
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Predicting a Bear Market: 7 Signs and Why it’s Tough to Do
Receive News & Ratings for Exicure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exicure and related companies with MarketBeat.com's FREE daily email newsletter.